Insuficiencia Cardíaca Avanzada e Transplante Cardíaco
Mayo Clinic
Rochester, Estados UnidosPublicacións en colaboración con investigadores/as de Mayo Clinic (7)
2024
-
Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy
European Journal of Heart Failure, Vol. 26, Núm. 3, pp. 612-615
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
-
The effect of long-term tafamidis treatment on quality of life in people with transthyretin amyloid cardiomyopathy (ATTR-CM): A plain language summary
Future Cardiology, Vol. 20, Núm. 11-12, pp. 595-603
2018
-
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure, Vol. 20, Núm. 1, pp. 16-37
2013
-
Availability and characteristics of cardiovascular rehabilitation programs in South America
Journal of Cardiopulmonary Rehabilitation and Prevention, Vol. 33, Núm. 1, pp. 33-41
2011
-
Report from a consensus conference on antibody-mediated rejection in heart transplantation
Journal of Heart and Lung Transplantation, Vol. 30, Núm. 3, pp. 252-269
2010
-
The international society of heart and lung transplantation guidelines for the care of heart transplant recipients
Journal of Heart and Lung Transplantation